Regeneron to defend against DOJ complaint on drug-price manipulation, ET HealthWorld

[ad_1] London: Regeneron Pharmaceuticals said on Monday it seeks to defend against U.S. Department of Justice‘s complaint that alleged the company misreported the average sales price of its macular degeneration drug Eylea. “Reimbursing credit card service fees to distributors is not a price concession and does not affect EYLEA’s price,” Regeneron said in a statement,…

Read More

Sheeva.AI enables in-vehicle payment technology for Citroen C3 Aircross SUV AT, ET Auto

[ad_1] Citroën C3 Aircross SUV AT New Delhi: Sheeva.AI has introduced in-vehicle payment technology through SheevaConnect product suite for Citroën C3 Aircross SUV AT, a budget-friendly automatic midsize SUV in India. The in-vehicle payments technology will allow the new Citroën C3 Aircross AT owners to pay for fuel at 32,000 fuelling stations across India. “We’re…

Read More

Boehringer replaces Bayer as Germany’s largest drugmaker on Jardiance gains, ET HealthWorld

[ad_1] By Patricia Weiss and Ludwig Burger London: Ingelheim: Boehringer Ingelheim on Tuesday overtook Bayer as Germany’s largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3 per cent to 20.8 billion euros ($22.11 billion). Diversified rival Bayer reported in March that 2023 sales at its pharmaceuticals division slipped…

Read More

Lam Research to donate software worth INR 241 cr to upskill semiconductor workforce in India, ET Auto

[ad_1] Combined with program management and course curriculum customization, the program is targeted to educate up to 60,000 Indian engineers in semiconductor fabrication technologies, over a 10 period. New Delhi: US-based semiconductor equipment company Lam Research Corp on Monday said it will donate software worth INR 241 crore to upskill workforce in India to meet…

Read More

Swiss online drug delivery firm DocMorris reports slight miss in Q1 sales, ET HealthWorld

[ad_1] London: Swiss online drug delivery company DocMorris slightly missed first-quarter sales expectations on Tuesday, as revenue from prescription medicines declined and e-prescriptions could not yet be redeemed fully digitally at online pharmacies. DocMorris posted external revenue of 262.4 million Swiss francs ($287.47 million), 1.4 per cent below analysts’ expectations according to a company-provided poll,…

Read More

Cipla to acquire Ivia Beaute’s cosmetics, personal care distribution and marketing biz for Rs 130 cr, ET HealthWorld

[ad_1] New Delhi: Pharma major Cipla Ltd will acquire the cosmetics and personal care distribution and marketing business of Ivia Beaute Pvt Ltd, including the latter’s brands Astaberry, Ikin and Bhimsaini, on a worldwide basis for Rs 130 crore, according to a regulatory filing by the company. Cipla Health Ltd (CHL), a wholly owned subsidiary…

Read More